Podcast Episodes
Back to Search
Pharmaceutical Executive Daily: China Approves Amgen's Tarlatamab for Previously Treated Extensive-Stage Small Cell Lung Cancer
In today's Pharmaceutical Executive Daily, China approves Amgen's tarlatamab for previously treated extensive-stage small cell lung cancer, a large s…
1 month, 1 week ago
Why Branding is Pharma’s Most Undervalued Asset
In this episode of Leading Edge With Ken Banta, The Vanguard Network founder and CEO is joined by branding strategist Andy Milligan, founding partne…
1 month, 1 week ago
Pharmaceutical Executive Daily: Shionogi Receives a Contract Through BARDA's Project BioShield
In today's Pharmaceutical Executive Daily, Shionogi receives a contract worth up to $482 million to bolster U.S. preparedness against drug-resistant …
1 month, 1 week ago
Pharmaceutical Executive Daily: Shah Capital's Plan to Vote Against Novavax Board Nominees
In today's Pharmaceutical Executive Daily, activist investor Shah Capital escalates its campaign against Novavax's board ahead of the company's annua…
1 month, 1 week ago
Pharmaceutical Executive Daily: Wegovy HD Now Available in the U.S.
In today's Pharmaceutical Executive Daily, Novo Nordisk launches Wegovy HD nationwide across the U.S., Gilead Sciences agrees to acquire German antib…
1 month, 1 week ago
Pharmaceutical Executive Daily: Neurocrine Biosciences Agrees to Acquire Soleno Therapeutics
In today's Pharmaceutical Executive Daily, Neurocrine Biosciences agrees to acquire Soleno Therapeutics for $2.9 billion to gain Vykat XR, the first …
1 month, 2 weeks ago
Pharmaceutical Executive Daily: President Trump Imposes 100% Tariff for Branded Pharmaceuticals
In today's Pharmaceutical Executive Daily, President Trump signs an executive order imposing 100% tariffs on imported patented pharmaceuticals under …
1 month, 2 weeks ago
Pharmaceutical Executive Daily: Leadership Turnover Under Trump Administration
In today’s Pharmaceutical Executive Daily, leadership turnover continues across key federal health agencies under the Trump administration, Shionogi …
1 month, 2 weeks ago
Pharmaceutical Executive Daily: Trump Administration Delays Appeal of Federal Ruling Blocking Vaccine Policy Overhaul
In today's Pharmaceutical Executive Daily, the Trump administration delays its appeal of the federal ruling blocking RFK Jr.'s vaccine policy overhau…
1 month, 2 weeks ago
Pharmaceutical Executive Daily: Novo Nordisk's Wegovy Subscription Program
In today's Pharmaceutical Executive Daily, Novo Nordisk launches the first multi-month subscription program for Wegovy targeting cash-paying patients…
1 month, 2 weeks ago